KYNTRA BIO, INC. Gain (Loss) on Disposition of Assets
KYNTRA BIO, INC. (KYNB) reported Gain (Loss) on Disposition of Assets of -$2.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-03-17
- KYNTRA BIO, INC. gain (loss) on disposition of assets for fiscal 2024 was -$2.50M.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2024-12-31 | -$2.50M 10-K · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |